지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2020.1
- 수록면
- 236 - 237 (2page)
이용수
초록· 키워드
오류제보하기
등록된 정보가 없습니다.
목차
등록된 정보가 없습니다.
참고문헌 (7)
참고문헌 신청
Nadia Soledad Alegre / 2020 / Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease / Clinical and Molecular Hepatology 26(2):216~226
Hardy T / 2016 / Nonalcoholic fatty liver disease : pathogenesis and disease spectrum / Annu Rev Pathol 11:451~496
Jeong-Ju Yoo / 2019 / Recent research trends and updates on nonalcoholic fatty liver disease / Clinical and Molecular Hepatology 25(1):1~11
Oh H / 2016 / Non-alcoholic fatty liver diseases : update on the challenge of diagnosis and treatment / Clin Mol Hepatol 22:327~335
Blom KG / 2009 / Isolation of murine intrahepatic immune cells employing a modified procedure for mechanical disruption and functional characterization of the B, T and natural killer T cells obtained / Clin Exp Immunol 155:320~329
Hardy T / 2016 / Nonalcoholic fatty liver disease : pathogenesis and disease spectrum / Annu Rev Pathol 11:451~496
Jeong-Ju Yoo / 2019 / Recent research trends and updates on nonalcoholic fatty liver disease / Clinical and Molecular Hepatology 25(1):1~11
Oh H / 2016 / Non-alcoholic fatty liver diseases : update on the challenge of diagnosis and treatment / Clin Mol Hepatol 22:327~335
Blom KG / 2009 / Isolation of murine intrahepatic immune cells employing a modified procedure for mechanical disruption and functional characterization of the B, T and natural killer T cells obtained / Clin Exp Immunol 155:320~329
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Limited expression of toll-like receptor 9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2020 .01
-
Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis?
Clinical and Molecular Hepatology
2020 .01
-
Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
Clinical and Molecular Hepatology
2023 .04
-
A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2022 .07
-
Personalized medicine in nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2022 .10
-
Experimental liver injury and nonalcoholic steatohepatitis animal models
한국실험동물학회 학술발표대회 논문집
2019 .07
-
Inhibition of liver X receptor attenuates nonalcoholic steatohepatitis by regulating differentiation of monocyte-derived macrophages
한국실험동물학회 학술발표대회 논문집
2022 .07
-
Alleviating lysosomal impairment in macrophages mitigates the progression of nonalcoholic steatohepatitis
한국실험동물학회 학술발표대회 논문집
2025 .02
-
The Immune Landscape in Nonalcoholic Steatohepatitis
Immune Network
2016 .06
-
Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait
Clinical and Molecular Hepatology
2022 .10
-
Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
Clinical and Molecular Hepatology
2023 .04
-
비알코올성 지방간염의 진단
대한내과학회지
2018 .01
-
Correlation between Transient Elastography (Fibroscan®) and Ultrasonographic and Computed Tomographic Grading in Pediatric Nonalcoholic Steatohepatitis
Pediatric Gastroenterology, Hepatology & Nutrition
2022 .05
-
Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
Clinical and Molecular Hepatology
2023 .02
-
Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights
Clinical and Molecular Hepatology
2020 .01
-
Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology
영남의대학술지
2019 .01
-
Hepatic serum amyloid A-1 aggravates T cell mediated hepatitis by inducing chemokines via Toll-like receptor 2 in mice
한국실험동물학회 학술발표대회 논문집
2015 .08
-
Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials
Clinical and Molecular Hepatology
2023 .02
-
Sarcopenia as a Novel Risk Factor for Nonalcoholic Fatty Liver Disease
Journal of Obesity & Metabolic Syndrome
2020 .01
-
The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
이 논문의 저자 정보
최근 본 자료
댓글(0)
0